Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 32Unknown 4Withdrawn 3Terminated 2Recruiting 2Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Healthy Adult Male 1Arthritis, Rheumatoid 1

Interventions

pembrolizumab 562Specimen Handling 490Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 406Radiotherapy 353Gemcitabine 314Bevacizumab 313Paclitaxel 298Biopsy 290Drug Therapy 283Blood Specimen Collection 248Capecitabine 245Oxaliplatin 241fludarabine 240Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 205Dexamethasone 187Radiosurgery 182Rituximab 159Standard of Care 158Pemetrexed 156Surgical Procedures, Operative 148durvalumab 145atezolizumab 145Leucovorin 139

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Adalimumab × Clear all
NCT06440629 2026-02-05

RA-DRUM

Diakonhjemmet Hospital

Phase 4 Recruiting
350 enrolled

Arthritis, Rheumatoid

NCT07181694 2025-10-03

A Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL in Healthy Subjects

Biocad

Phase 1 Recruiting
444 enrolled

Healthy Adult Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡